Managers / Q3 2021 · view latest →
Roumell Asset Management, LLC
CIK 0001331693 · 2 WISCONSIN CIR, SUITE 700, CHEVY CHASE, MD, 20815 · 301-656-8500
Summary
Roumell Asset Management, LLC reported $75M in U.S.-listed holdings across 17 positions for Q3 2021.
Its largest position, GSIT, represents 13.7% of the portfolio.
Compared with Q2 2021, the fund opened 4 new positions and exited 5.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 64.4% · $49M
- Other · 26.2% · $20M
- ADR · 9.4% · $7M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| EHTHEHEALTH INC | NEW | +171.2K | 171.2K | +$7M | $7M |
| COMSCORE INC | NEW | +865.4K | 865.4K | +$3M | $3M |
| QUMU CORP | NEW | +1.10M | 1.10M | +$3M | $3M |
| SPARK NETWORKS SE | NEW | +240.8K | 240.8K | +$845,000 | $845,000 |
| SWCHFSIERRA WIRELESS INC | SOLD OUT | −200.5K | 0 | −$4M | $0 |
| MGNIMAGNITE INC | SOLD OUT | −100.0K | 0 | −$3M | $0 |
| VENUS CONCEPT INC | SOLD OUT | −881.8K | 0 | −$3M | $0 |
| EXTERRAN CORP | SOLD OUT | −468.6K | 0 | −$2M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | GSITGSI TECHNOLOGY INChistory → | COM | 13.68% | $10M | 1.96M |
| 2 | ENZBENZO BIOCHEM INChistory → | COM | 13.54% | $10M | 2.89M |
| 3 | COLLPLANT BIOTECHNOLOGIES LT | SHS NEW | 12.59% | $10M | 563.0K |
| 4 | QUANTUM CORP | COM NEW | 10.74% | $8M | 1.56M |
| 5 | ALLOT LTD | SHS | 9.85% | $7M | 500.2K |
| 6 | EHTHEHEALTH INChistory → | COM | 9.19% | $7M | 171.2K |
| 7 | OPRAOPERA LTDhistory → | SPONSORED ADS | 8.26% | $6M | 704.5K |
| 8 | COMSCORE INC | COM | 4.47% | $3M | 865.4K |
| 9 | BCDABIOCARDIA INChistory → | COM | 3.90% | $3M | 938.4K |
| 10 | QUMU CORP | COM | 3.61% | $3M | 1.10M |
| 11 | STREAMLINE HEALTH SOLUTIONS | COM | 2.35% | $2M | 1.01M |
| 12 | NODKNI HLDGS INChistory → | COM | 1.91% | $1M | 82.1K |
| 13 | ARDSARIDIS PHARMACEUTICALS INChistory → | COM | 1.69% | $1M | 347.5K |
| 14 | EROS STX GLOBAL CORPORATION | SHS NEW | 1.40% | $1M | 1.15M |
| 15 | SPARK NETWORKS SE | SPONSORED ADR | 1.12% | $845,000 | 240.8K |
| 16 | RICEBRAN TECHNOLOGIES | COM NEW | 1.11% | $835,000 | 1.41M |
| 17 | CLMBWAYSIDE TECHNOLOGY GROUP INC | COM | 0.60% | $453,000 | 16.8K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2024 | $53M | 16 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $53M | 17 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $47M | 15 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $50M | 19 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $51M | 22 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $44M | 20 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $40M | 21 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $46M | 21 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $51M | 21 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $62M | 19 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $75M | 21 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $75M | 17 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $86M | 18 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $69M | 14 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $64M | 16 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $50M | 14 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $41M | 20 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $37M | 22 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $44M | 21 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $42M | 14 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $42M | 18 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $41M | 20 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $48M | 22 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.